미국 요오드화 칼륨 보충제 공급업체 및 가격 — 마켓 오버뷰 2026

상위 제품

요오드 보충제

최종 업데이트

2026-06-23

서치 및 소싱 팀을 위한 핵심 요약

미국의 요오드화 칼륨 보충제 마켓 인텔리전스 페이지에는 프리미엄 공급업체 0개가 포함되어 있습니다.
미국에 대한 샘플 수출 거래 0건이 요약되어 있습니다.
미국의 요오드화 칼륨 보충제에 대해 수출 파트너 기업 0개와 수입 파트너 기업 2개가 매핑되어 있습니다.
도매 샘플 항목: 0건; 산지가 샘플 항목: 0건.
수출 파트너 국가 0개와 수입 파트너 국가 0개가 랭킹되어 있습니다.
페이지 데이터 최종 업데이트일: 2026-06-23.

미국의 요오드화 칼륨 보충제 수입 바이어 인텔리전스 및 가격 시그널: 바이어, 수요, 거래 파트너

미국의 요오드화 칼륨 보충제에 대해 수입 파트너 기업 2개가 추적됩니다. 수출업체와 수입업체는 Supply Chain Intelligence 회사 프로필 및 분석을 활용해 바이어 수요, 파트너 밀도, 다운스트림 채널을 분석할 수 있습니다.

스캐터 포인트는 전체 거래 데이터셋의 100.0%에서 샘플링되었습니다.

요오드화 칼륨 보충제의 미국 샘플 수입 거래 및 가격 기록

미국의 요오드화 칼륨 보충제 샘플 수입 거래 5건은 가격 수준과 수요 측 거래 패턴 벤치마킹을 위한 날짜, 원산지, 무역 국가 맥락을 제공합니다.

미국의 요오드화 칼륨 보충제 샘플 수입 거래 단가(일자별): 2026-02-20: 11.92 USD / kg, 2026-01-21: 8.40 USD / kg, 2026-01-21: 12.11 USD / kg, 2026-01-10: 12.04 USD / kg, 2025-05-31: 13.40 USD / kg.

일자	신고 품목	단가	수출업체	수입업체	원산지
2026-02-20	Foo* * ***** ******* **** * * ***** *** *****	11.92 USD / kg	(-)	(-)	-
2026-01-21	Foo* * ***** ******* **** * * ***** *** *****	8.40 USD / kg	(-)	(-)	-
2026-01-21	Foo* * ***** ******* **** * * ***** *** *****	12.11 USD / kg	(-)	(-)	-
2026-01-10	Foo* * ***** ******* **** * * ***** *** *****	12.04 USD / kg	(-)	(-)	-
2025-05-31	Foo* * ***** ******* **** * * ***** *** *****	13.40 USD / kg	(-)	(-)	-

미국 내 상위 요오드화 칼륨 보충제 바이어, 수입업체 및 수요 파트너

선도 바이어 프로필을 검토하고 미국의 요오드화 칼륨 보충제에 대해 추적되는 전체 수입 파트너 기업 2개와 비교하세요. 수출업체와 수입업체는 Supply Chain Intelligence 회사 프로필 및 분석으로 수요 측 파트너 적합도를 평가할 수 있습니다.

(미국)

최근 수입 거래: 2026-05-23

임직원 규모: 직원 101 - 500명

매출액: 매출 USD 10M - 50M

산업군: 음료 제조식품 제조식품 포장

밸류체인 역할: 유통 / 도매식품 제조

(미국)

최근 수입 거래: 2026-05-23

임직원 규모: 직원 1000명 초과

매출액: 매출 USD 1B 초과

산업군: 식품 제조식품 도매온라인 리테일 및 풀필먼트기타

밸류체인 역할: 유통 / 도매소매무역

미국 수입 파트너 커버리지

2개 기업

수입 파트너 기업 수는 미국의 요오드화 칼륨 보충제 수요 측 가시성을 보여줍니다.

공급망 인텔리전스 분석과 기업 프로필을 활용해 미국에서 활동 중인 요오드화 칼륨 보충제 수입업체, 유통업체, 바이어 네트워크를 식별하세요.

Classification

Product TypeProcessed Food

Product FormFinished dietary supplement (tablets/capsules)

Industry PositionConsumer Health Product (Dietary Supplement)

Market

Potassium iodide (KI) products in the United States sit at the intersection of dietary supplement rules and, when positioned for radiation emergency thyroid blocking, drug-regulated use. The U.S. is a large consumer market with extensive domestic contract manufacturing and significant reliance on imported raw materials and finished supplement products. Market access is primarily determined by regulatory classification, GMP compliance, and labeling/claims discipline rather than agricultural seasonality. Demand can become highly event-driven during nuclear incident news cycles, increasing stock-out and counterfeit/misbranding risk.

Market RoleDomestic consumer and manufacturing market; imports both finished supplements and inputs; regulatory/claims-driven market access

Domestic RoleRetail dietary supplement market with strong compliance emphasis (cGMP, labeling, claims substantiation); KI also has drug-regulated emergency-use context when marketed for thyroid blocking in radiation emergencies

Specification

Physical Attributes

Sold primarily as solid oral dosage forms (tablets/capsules); some products may be liquids/drops depending on brand positioning
Packaging commonly emphasizes moisture protection (e.g., tight-closure bottles; desiccant use varies by manufacturer)

Compositional Metrics

Label potency typically declared as iodine content or KI equivalent (labeling conventions vary by product positioning)
Identity and potency testing frequently references pharmacopeial expectations (e.g., USP compendial approaches) or validated in-house methods

Grades

Specifications may reference USP/compendial grade for the active ingredient where applicable

Packaging

HDPE or similar bottles with child-resistant closures (channel-dependent)
Blister packs (channel-dependent)

Supply Chain

Value Chain

KI raw material sourcing (often imported) → incoming identity/potency testing → blending with excipients → tablet compression or capsule filling → in-process checks → packaging and labeling → distribution to retail/online channels

Temperature

Ambient distribution typical; protect from heat extremes during storage and transport to preserve label potency over shelf life

Atmosphere Control

Moisture and light control are common stability considerations for iodide-containing products; packaging selection and desiccant strategy are key design levers

Shelf Life

Solid dosage forms are generally more shelf-stable than liquids when appropriately packaged; humidity exposure can increase degradation/discoloration risk

Freight IntensityLow

Transport ModeMultimodal

Risks

Regulatory Compliance HighRegulatory classification and claims risk is the primary deal-breaker: KI marketed or implied for radiation emergency thyroid blocking (or other disease-related purposes) can be treated as a drug-regulated product in the U.S.; misclassification, misbranding, or unapproved drug claims can lead to detention, refusal, seizure, or rapid enforcement actions.Lock intended use and claims with regulatory review; keep supplement marketing within allowable structure/function boundaries and labeling requirements; if positioning is for radiation emergency use, follow the applicable FDA drug framework rather than supplement rules.

Food Safety MediumIdentity/potency variability and contamination risk (including supplier fraud or inadequate incoming testing) can trigger recalls, retailer delistings, and FDA enforcement, especially for mineral ingredients where assay and impurity controls are central to quality.Use qualified suppliers, documented identity testing for each lot, and stability programs supporting label claims; consider third-party verification where commercially important.

Market Volatility MediumEvent-driven demand surges (e.g., during nuclear incident news cycles) can create abrupt shortages, price spikes, and increased counterfeit/misbranding pressure in online channels.Implement channel monitoring, conservative claims controls, anti-counterfeit measures for e-commerce, and contingency inventory planning for critical SKUs.

Logistics LowWhile freight cost exposure is typically lower than for bulky foods, cross-border clearance delays (holds, exams, detention) can disrupt availability and raise costs, particularly for imported finished goods.Pre-align documentation and compliance dossier; maintain U.S. inventory buffers for key retail programs; use experienced customs/FDA import brokers.

Standards

USP Verified Dietary Supplements (voluntary, brand-dependent)
NSF certification programs (voluntary, channel-dependent)

FAQ

Can a potassium iodide product be sold in the U.S. as a dietary supplement if it is marketed for radiation protection?High-risk: if the product is marketed or implied for radiation emergency thyroid blocking, it can be treated as a drug-regulated product in the U.S. Claims and intended use drive classification, so supplement-style marketing for radiation protection can trigger enforcement.

What are the main U.S. compliance pillars for a potassium iodide dietary supplement?The core pillars are dietary supplement cGMP compliance (21 CFR Part 111), accurate labeling and non-drug claims discipline, and quality controls demonstrating identity and potency (supported by COAs and testing records). Imports also need proper CBP entry handling and FDA-related import processes, including Prior Notice where applicable.

What quality controls are most important for KI supplement manufacturing and release in the U.S.?Incoming ingredient identity testing, potency/assay testing, impurity controls appropriate to the specification, and stability support for label claims are the most important controls, backed by batch records and traceability for recall readiness.